{
  "qna_result": {
    "Q0": {
      "answer": "CMA",
      "reasoning": "Patient information explicitly states 'chromosomal microarray (CMA) testing ... is being requested.' Basis: patient clinical info."
    },
    "Q1": {
      "answer": "Not Specified",
      "reasoning": "The Cigna epilepsy guideline defines clinical diagnoses (eg, early infantile epileptic encephalopathy, neonatal seizures) but does not state an explicit age cutoff requirement for CMA; age-based eligibility criteria are not specified for CMA in the policy."
    },
    "Q2": {
      "answer": "Not Specified",
      "reasoning": "The policy requires the rendering laboratory be qualified but does not specify ordering-provider specialty or other provider requirements for CMA; no explicit ordering-provider criteria for this test are provided."
    },
    "Q3": {
      "answer": "Not Specified",
      "reasoning": "The guideline specifies medical necessity criteria for epilepsy single-gene tests and multigene panels (eg, early infantile epileptic encephalopathy) but does not provide explicit coverage/medical-necessity criteria specific to CMA; although the patient meets diagnostic features (neonatal epileptic encephalopathy), CMA-specific indications are not defined in the policy."
    },
    "Q4": {
      "answer": "Not Specified",
      "reasoning": "The policy does not list required prior tests before performing CMA. Although the patient had a prior nondiagnostic CMA, the guideline does not specify prior-testing prerequisites for CMA."
    },
    "Q5": {
      "answer": "No",
      "reasoning": "The guideline does list family history as a specific criterion for some epilepsy panel indications (eg, focal epilepsy with positive family history suggestive of monogenic inheritance). The patientâ€™s family history is an older sibling with unexplained developmental regression (not described as epilepsy or a family history suggestive of monogenic epilepsy), so it does not meet the family-history criterion as specified in the policy."
    },
    "Q6": {
      "answer": "Not Specified",
      "reasoning": "Although the patient notes pre-test counseling occurred, the Cigna guideline does not list genetic counseling as an explicit coverage requirement for CMA; counseling is recommended by professional groups but is not defined as a coverage prerequisite in the policy."
    },
    "Q7": {
      "answer": "Not Specified",
      "reasoning": "The policy lists many CPT codes for epilepsy gene tests and discusses CGH/CMA conceptually, but it does not provide a specific CPT code for chromosomal microarray within the document. None of the provided answer choices are explicitly linked to CMA in the policy text."
    },
    "Q8": {
      "answer": "No",
      "reasoning": "The requested test is CMA, but the Cigna epilepsy guideline's coverage criteria focus on single-gene testing, multigene panels, ES/GS and do not define CMA-specific medical-necessity criteria. Additionally the patient already had a prior nondiagnostic CMA. Based strictly on the policy text (no explicit CMA coverage criteria and emphasis on panels/ES/GS for neonatal epileptic encephalopathy), the requested repeat CMA is not supported as meeting explicit coverage criteria."
    }
  },
  "token_usage": {
    "input_tokens": 12764,
    "output_tokens": 2735,
    "total_tokens": 15499
  }
}